BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28503836)

  • 21. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
    Hsu WH; Wen YW; Chen LK; Hsiao FY
    Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticholinergic medication burden and cognitive function in participants of the ASPREE study.
    Broder JC; Ryan J; Shah RC; Lockery JE; Orchard SG; Gilmartin-Thomas JF; Fravel MA; Owen AJ; Woods RL; Wolfe R; Storey E; Murray AM; Ernst ME
    Pharmacotherapy; 2022 Feb; 42(2):134-144. PubMed ID: 34866212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The excess mortality risk associated with anticholinergic burden among older patients discharged from acute care hospital with depressive symptoms.
    Corsonello A; Cozza A; D'Alia S; Onder G; Volpato S; Ruggiero C; Cherubini A; Di Rosa M; Fabbietti P; Lattanzio F
    Eur J Intern Med; 2019 Mar; 61():69-74. PubMed ID: 30449478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
    Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
    J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study.
    Lechevallier-Michel N; Molimard M; Dartigues JF; Fabrigoule C; Fourrier-Réglat A
    Br J Clin Pharmacol; 2005 Feb; 59(2):143-51. PubMed ID: 15676035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients.
    Pfistermeister B; Tümena T; Gaßmann KG; Maas R; Fromm MF
    PLoS One; 2017; 12(2):e0171353. PubMed ID: 28187171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study.
    Ehrt U; Broich K; Larsen JP; Ballard C; Aarsland D
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):160-5. PubMed ID: 19770163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticholinergic Cognitive Burden in Older People Over Acute Admission.
    Rice SD; Kim N; Farris C
    Sr Care Pharm; 2021 Feb; 36(2):104-111. PubMed ID: 33509334
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of Anticholinergic Drug Burden With Cognitive and Functional Decline Over Time in Dementia With Lewy Bodies: 1-Year Follow-Up Study.
    Ozsurekci C; Satis NK; Demircan SK; Naharci MI
    Clin Neuropharmacol; 2024 Mar-Apr 01; 47(2):48-53. PubMed ID: 38478365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.
    Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Wolfe R; Connors MH; Elliott RA
    J Alzheimers Dis; 2017; 60(2):349-358. PubMed ID: 28869467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Joshi YB; Thomas ML; Braff DL; Green MF; Gur RC; Gur RE; Nuechterlein KH; Stone WS; Greenwood TA; Lazzeroni LC; MacDonald LR; Molina JL; Nungaray JA; Radant AD; Silverman JM; Sprock J; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Swerdlow NR; Light GA
    Am J Psychiatry; 2021 Sep; 178(9):838-847. PubMed ID: 33985348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticholinergic burden is associated with recurrent and injurious falls in older individuals.
    Zia A; Kamaruzzaman S; Myint PK; Tan MP
    Maturitas; 2016 Feb; 84():32-7. PubMed ID: 26531071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
    Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
    Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
    Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
    Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
    Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
    Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticholinergic drugs and risk of dementia: case-control study.
    Richardson K; Fox C; Maidment I; Steel N; Loke YK; Arthur A; Myint PK; Grossi CM; Mattishent K; Bennett K; Campbell NL; Boustani M; Robinson L; Brayne C; Matthews FE; Savva GM
    BMJ; 2018 Apr; 361():k1315. PubMed ID: 29695481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticholinergic Medication Burden and 5-Year Risk of Hospitalization and Death in Nursing Home Elderly Residents With Coronary Artery Disease.
    Vetrano DL; La Carpia D; Grande G; Casucci P; Bacelli T; Bernabei R; Onder G;
    J Am Med Dir Assoc; 2016 Nov; 17(11):1056-1059. PubMed ID: 27590402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.
    Fox C; Richardson K; Maidment ID; Savva GM; Matthews FE; Smithard D; Coulton S; Katona C; Boustani MA; Brayne C
    J Am Geriatr Soc; 2011 Aug; 59(8):1477-83. PubMed ID: 21707557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study.
    Dos Santos ANM; Junior GAAG; Benseñor IM; Goulart AC; Brunoni AR; Viana MC; Lotufo PA; Suemoto CK
    Eur J Clin Pharmacol; 2022 Sep; 78(9):1527-1534. PubMed ID: 35764818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.